CAMILLE CONGER: Open Payments
NPI 1275174468 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,287 in 113 payments from 26 companies in 2025. Trend: 2023 $2,529 · 2024 $1,681 · 2025 $3,287
Food & beverage: $3,028Education: $260
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $621 |
| GENZYME CORPORATION | 15 | $527 |
| GlaxoSmithKline, LLC. | 14 | $211 |
| Regeneron Healthcare Solutions, Inc. | 6 | $200 |
| Actelion Pharmaceuticals US, Inc. | 4 | $196 |
| Inspire Medical Systems, Inc. | 4 | $176 |
| Axsome Therapeutics, Inc. | 5 | $136 |
| HARMONY BIOSCIENCES LLC | 4 | $135 |
| Viatris Specialty LLC | 5 | $126 |
| Pulmonx Corporation | 5 | $105 |
Products named: DUPIXENT, TEZSPIRE, INSPIRE, OPSUMIT, Sunosi, Xolair, YUPELRI, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
